Public list Pharma Startups (4732):
CytoGuide focuses on the development of two-component drugs that has the potential to maximise the effectiveness of a well-known Rheumatoid Arthritis treatment while drastically minimising its side effects.
Company (Alive / Active)
INCUBA Science Park
Gustav Wieds Vej 10
|Investor||Investor Type||Location||Participating Rounds|
|Laval, Quebec, Canada||Alive / Active||Labopharm is an international, specialty pharmaceutical company that develops improved formulations of currently marketed drugs using the Company's advanced, controlled-release technologies. Labopharm's strategy is to leverage these technologies to develop and commercialize new formulations of existing products that address the market's preference for drugs that offer simplified dosing regimens, improved efficacy or a reduced side effect profile.||Login to see details|
|Alpharetta, Georgia, United States||Alive / Active||AtheroGenics is an emerging pharmaceutical company, focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as heart disease (atherosclerosis), asthma and arthritis. Based on a proprietary drug discovery technology platform called vascular protectant technology, the company designed its lead product candidate, AGI-1067, to benefit patients with coronary artery disease, which is atherosclerosis of the blood vessels of the...Show all||Login to see details|